Glaukos Quick Ratio 2014-2024 | GKOS
Glaukos Quick Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
2024-09-30 | $0.34B | $0.07B | 4.71 |
2024-06-30 | $0.33B | $0.07B | 4.67 |
2024-03-31 | $0.34B | $0.07B | 4.69 |
2023-12-31 | $0.35B | $0.07B | 4.78 |
2023-09-30 | $0.36B | $0.07B | 5.36 |
2023-06-30 | $0.36B | $0.06B | 5.66 |
2023-03-31 | $0.38B | $0.06B | 6.02 |
2022-12-31 | $0.41B | $0.07B | 5.61 |
2022-09-30 | $0.42B | $0.06B | 6.84 |
2022-06-30 | $0.44B | $0.07B | 6.38 |
2022-03-31 | $0.47B | $0.06B | 8.39 |
2021-12-31 | $0.46B | $0.06B | 7.31 |
2021-09-30 | $0.48B | $0.06B | 7.60 |
2021-06-30 | $0.47B | $0.35B | 1.35 |
2021-03-31 | $0.46B | $0.34B | 1.37 |
2020-12-31 | $0.45B | $0.05B | 9.13 |
2020-09-30 | $0.44B | $0.05B | 9.31 |
2020-06-30 | $0.43B | $0.06B | 7.88 |
2020-03-31 | $0.20B | $0.05B | 3.99 |
2019-12-31 | $0.22B | $0.06B | 3.82 |
2019-09-30 | $0.20B | $0.03B | 5.94 |
2019-06-30 | $0.19B | $0.03B | 6.04 |
2019-03-31 | $0.17B | $0.03B | 6.23 |
2018-12-31 | $0.16B | $0.03B | 5.38 |
2018-09-30 | $0.16B | $0.03B | 6.53 |
2018-06-30 | $0.14B | $0.02B | 6.95 |
2018-03-31 | $0.14B | $0.02B | 7.22 |
2017-12-31 | $0.14B | $0.03B | 5.16 |
2017-09-30 | $0.13B | $0.02B | 6.48 |
2017-06-30 | $0.12B | $0.02B | 6.42 |
2017-03-31 | $0.12B | $0.02B | 7.94 |
2016-12-31 | $0.11B | $0.02B | 6.68 |
2016-09-30 | $0.11B | $0.02B | 5.74 |
2016-06-30 | $0.11B | $0.02B | 5.72 |
2016-03-31 | $0.10B | $0.02B | 5.53 |
2015-12-31 | $0.10B | $0.02B | 4.91 |
2015-09-30 | $0.10B | $0.02B | 5.17 |
2015-06-30 | $0.11B | $0.02B | 5.19 |
2015-03-31 | $0.01B | $0.02B | 0.60 |
2014-12-31 | $0.01B | $0.02B | 0.41 |
2014-09-30 | $0.00B | 0.00 | |
2014-06-30 | $0.00B | 0.00 | |
2014-03-31 | $0.00B | 0.00 | |
2013-12-31 | $0.01B | $0.01B | 1.85 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $7.026B | $0.315B |
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $214.502B | 26.17 |
Intuitive Surgical (ISRG) | United States | $183.493B | 95.93 |
Alcon (ALC) | Switzerland | $45.596B | 32.10 |
Edwards Lifesciences (EW) | United States | $40.174B | 24.98 |
IQVIA Holdings (IQV) | United States | $38.636B | 21.29 |
IDEXX Laboratories (IDXX) | United States | $34.062B | 40.11 |
DexCom (DXCM) | United States | $26.951B | 40.59 |
Waters (WAT) | United States | $22.989B | 33.99 |
STERIS (STE) | Ireland | $22.429B | 26.17 |
SONOVA HOLDING (SONVY) | Switzerland | $22.309B | 0.00 |
Hologic (HOLX) | United States | $18.303B | 19.31 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.930B | 12.25 |
Sysmex ADR (SSMXY) | Japan | $11.738B | 36.81 |
Globus Medical (GMED) | United States | $10.234B | 26.06 |
Teleflex (TFX) | United States | $9.451B | 15.07 |
Penumbra (PEN) | United States | $8.919B | 87.36 |
Masimo (MASI) | United States | $8.063B | 39.26 |
PROCEPT BioRobotics (PRCT) | United States | $4.981B | 0.00 |
Integer Holdings (ITGR) | United States | $4.316B | 24.46 |
Inari Medical (NARI) | United States | $2.930B | 0.00 |
TransMedics (TMDX) | United States | $2.786B | 88.30 |
Veracyte (VCYT) | United States | $2.760B | 171.10 |
LivaNova (LIVN) | United Kingdom | $2.698B | 15.58 |
Nihon Kohden (NHNKY) | Japan | $2.530B | 15.74 |
Elekta AB (EKTAY) | Sweden | $2.292B | 18.67 |
Tandem Diabetes Care (TNDM) | United States | $2.168B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.922B | 10.04 |
RxSight (RXST) | United States | $1.913B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.216B | 0.00 |
Artivion (AORT) | United States | $1.168B | 107.27 |
OPKO Health (OPK) | United States | $1.018B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.013B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.909B | 15.45 |
OrthoPediatrics (KIDS) | United States | $0.722B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.695B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.676B | 0.00 |
IRadimed (IRMD) | United States | $0.668B | 36.12 |
AxoGen (AXGN) | United States | $0.656B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.653B | 16.50 |
SiBone (SIBN) | United States | $0.607B | 0.00 |
Paragon 28 (FNA) | United States | $0.522B | 0.00 |
CVRx (CVRX) | United States | $0.374B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.358B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.354B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.322B | 17.44 |
Delcath Systems (DCTH) | United States | $0.303B | 0.00 |
AngioDynamics (ANGO) | United States | $0.284B | 0.00 |
Semler Scientific (SMLR) | United States | $0.273B | 19.02 |
Sight Sciences (SGHT) | United States | $0.237B | 0.00 |
Inogen (INGN) | United States | $0.219B | 0.00 |
Nevro (NVRO) | United States | $0.207B | 0.00 |
NeuroPace (NPCE) | United States | $0.204B | 0.00 |
Accuray (ARAY) | United States | $0.193B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.176B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.159B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
908 Devices (MASS) | United States | $0.127B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.122B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.107B | 15.98 |
EDAP TMS S.A (EDAP) | France | $0.102B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.078B | 0.00 |
Hyperfine (HYPR) | United States | $0.071B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.067B | 0.00 |
LENSAR (LNSR) | United States | $0.067B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
InspireMD (NSPR) | Israel | $0.060B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.048B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.047B | 0.00 |
Envoy Medical (COCH) | United States | $0.042B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
Neuronetics (STIM) | United States | $0.034B | 0.00 |
DarioHealth (DRIO) | United States | $0.028B | 0.00 |
Spectral AI (MDAI) | United States | $0.027B | 0.00 |
Precision Optics (POCI) | United States | $0.027B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.027B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
NexGel (NXGL) | United States | $0.018B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.014B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |